Beyond LDL: Understanding Triglyceride-Rich Lipoproteins to Tackle Residual Risk.

Published in: Journal of clinical medicine (2023)

For the past 30 years, statin therapy has been the cornerstone for the reduction in the risk of atherosclerotic cardiovascular disease (ASCVD) [...].

Keyphrases